Acute dystonia during pegylated interferon alpha therapy in a case with chronic hepatitis B infection.

Interferon (IFN) is the most widely prescribed drug of choice for chronic hepatitis B infection, which is a common health problem in our country. Therapy with IFN-alpha may be associated with a number of neuropsychiatric symptoms, such as Parkinsonism, akathisia, seizure, and depressive disorders. In this case report, we present clinical and laboratory findings of a case with chronic hepatitis B that developed acute dystonia soon after the first dose of pegylated interferon alpha. As far as we know, this is the first report in English literature indicating such an adverse effect of pegylated interferon alpha.

[1]  E. Tan,et al.  “Myorhythmia” slow facial tremor from chronic interferon alpha-2a usage , 2003, Neurology.

[2]  C. Crone,et al.  Comprehensive Review of Hepatitis C for Psychiatrists: Risks, Screening, Diagnosis, Treatment, and Interferon-Based Therapy Complications , 2003, Journal of psychiatric practice.

[3]  R. Zittoun,et al.  Recombinant interferon-α–induced chorea and frontal subcortical dementia , 2002, Neurology.

[4]  B. Redman,et al.  Psychiatric side effects of interferon therapy: prevalence, proposed mechanisms, and future directions. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  T. Nishikawa,et al.  Intravenous administration of levodopa ameliorated a refractory akathisia case induced by interferon-alpha. , 2000, Clinical neuropharmacology.

[6]  N. Horikawa,et al.  The disclosure of information to cancer patients and its relationship to their mental state in a consultation-liaison psychiatry setting in Japan. , 1999, General hospital psychiatry.

[7]  N. Horikawa,et al.  A case of akathisia during interferon-alpha therapy for chronic hepatitis type C. , 1999, General hospital psychiatry.

[8]  R. Oishi,et al.  Repeated interferon-α administration inhibits dopaminergic neural activity in the mouse brain , 1997, Brain Research.

[9]  R. Scheibel,et al.  Neurotoxicity of intraventricularly administered alpha‐interferon for leptomeningeal disease , 1991, Cancer.

[10]  M. Inbar,et al.  Interferon-related mental deterioration and behavioral changes in patients with renal cell carcinoma. , 1990, European journal of cancer.

[11]  V. Bocci.  Central nervous system toxicity of interferons and other cytokines. , 1988, Journal of biological regulators and homeostatic agents.